Investor Presentaiton

= Building leadership positions in an industry with significant network effects and competitive advantage for the market leader eurofins • High barriers to entry High level of investment and innovation required to build and efficiently run a network of modern laboratories (buildings, equipment, IT infrastructure and solutions, talent) • Clients seldom change laboratory supplier (high switching costs) • Clients increasingly expect a complete range of tests at very short turnaround times (TATS) Reinforcing leadership positions Scale matters K • • Generating synergies . • • • Unique ability to offer our clients access to a portfolio of over 200,000 different tests across more than 50 countries thanks to state-of-the-art global laboratory network Scale & volume required for short TATS on complex tests Unique ability to offer one-stop shops to our clients thanks to advanced bespoke IT solutions Hub and spoke model to generate scale for complex tests Network effect/cross-selling synergies Site specialization drives cost synergies (efficiency - each method requires heavy investment and thus needs to be amortized over large volumes, purchasing power) Innovation/R&D synergies We have been building a hard to replicate laboratory platform Some competitors who tried to diversify into our sector are starting to exit some of our markets (LabCorp, Exova, TÜV Rheinland, Applus etc.). Smaller/mid-size players lose market share 333

View entire presentation